Kenrick Ng

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Prostate cancer and prostatic diseases

Oncology and therapy

JCO oncology practice

BJU international

University College London Hospitals NHS Foundation Trust

School of Clinical Medicine, University of Cambridge (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Hospitals NHS Foundation Trust

United Kingdom

Honorary Clinical Research Fellow :: NIHR Clinical Research Facility

University College London Sep 24 2018 - Sep 04 2021

United Kingdom

Clinical Research Training Fellow :: Cancer Institute

Education History

School of Clinical Medicine, University of Cambridge

United Kingdom

BSC

University of Cambridge

United Kingdom

MSC

Publications

Yan Hiu Athena Lee, Jeremy Man Ho Hui, Steven Chi Ho Leung, Christopher Tze-Wei Tsang, Kyle Hui, Pias Tang, Jeffrey Shi Kai Chan, Edward Christopher Dee, Kenrick Ng, Sean McBride, Paul L Nguyen, Gary Tse, Chi-Fai Ng
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study. Prostate cancer and prostatic diseases (2023)
Jeffrey Shi Kai Chan, Oscar Hou-In Chou, Teddy Tai Loy Lee, Yan Hiu Athena Lee, Raymond Ngai Chiu Chan, Edward Christopher Dee, Kenrick Ng, Tong Liu, Gary Tse
Temporal trends in guideline-recommended cardiometabolic testing completeness before initiating immune checkpoint inhibitors: A cohort study. Journal of internal medicine (2023)
Kenrick Ng, Rob Metcalf, Joseph Sacco, Anthony Kong, Graham Wheeler, Sharon Forsyth, Reshma Bhat, Joseph Ward, Leah Ensell, Helen Lowe, Victoria Spanswick, John Hartley, Laura White, Elizabeth Lloyd-Dehler, Martin Forster
Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK. BMJ open 13 (11) (2023)
Jeffrey Shi Kai Chan, Danish Iltaf Satti, Yan Hiu Athena Lee, Jeremy Man Ho Hui, Edward Christopher Dee, Kenrick Ng, Kang Liu, Gary Tse, Chi-Fai Ng
Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study. British journal of cancer (2023)
Nishwant S Swami, Yefri A Baez, Idalid Franco, Tiffany Nguyen, Karthik Meiyappan, Minh Ton, Bhav Jain, Crystal Seldon, Kenrick Ng, Narjust Duma, Mohammed Alshalalfa, Kosj Yamoah, Paul L Nguyen, Brandon A Mahal, Edward Christopher Dee
Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate cancer and prostatic diseases (2022)
Raymond Ngai Chiu Chan, Teddy Tai Loy Lee, Oscar Hou In Chou, Jenny So, Cheuk To Chung, Edward Christopher Dee, Kenrick Ng, Pias Tang, Leonardo Roever, Tong Liu, Wing Tak Wong, Gary Tse, Sharen Lee
Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. Journal of the Endocrine Society 6 (11) (2022)
Valentí Gómez, Myria Galazi, Gregory Weitsman, James Monypenny, Fahad Al-Salemee, Paul R Barber, Kenrick Ng, Richard Beatson, Bálint Szokol, László Őrfi, Greg Mullen, Bart Vanhaesebroeck, Simon Chowdhury, Hing Y Leung, Tony Ng
HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models. Molecular cancer therapeutics 21 (4) (2022)
Kenrick Ng, Peter Wilson, Katherine Mutsvangwa, Luke Hounsome, Jonathan Shamash
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England. Prostate cancer and prostatic diseases 24 (3) (2021)
Melek Akay, Ionut-Gabriel Funingana, Grisma Patel, Rami Mustapha, Ernese Gjafa, Tony Ng, Kenrick Ng, Michael J Flynn
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions. Oncology and therapy 9 (2) (2021)
Bhav Jain, Kenrick Ng, Patricia Mae G Santos, Kekoa Taparra, Vinayak Muralidhar, Brandon A Mahal, Neha Vapiwala, Quoc Dien Trinh, Paul L Nguyen, Edward Christopher Dee
Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic Groups. JCO oncology practice (2021)
Kenrick Ng, Krishna Vinnakota, Anand Sharma, John Kelly, Prokar Dasgupta, Nikhil Vasdev
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era. Nature reviews. Urology 18 (4) (2021)
Lara Pemberton, Kenrick Ng, Ursula McGovern, Alan Macdonald, Hasti Barot, Myria Galazi, Peter Wilson, Paula Wells, Mark Linch, Constantine Alifrangis, Jonathan Shamash
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxis. Prostate cancer and prostatic diseases 24 (1) (2020)
Ernese Gjafa, Kenrick Ng, Tami Grunewald, Myria Galazi, Erik Skyllberg, Peter Wilson, Constantine Alifrangis, Jonathan Shamash
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen. BJU international 127 (2) (2020)
Kenrick Ng, Shievon Smith, Jonathan Shamash
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting. Oncology and therapy 8 (2) (2020)
Tony Collier, Shievon Smith, Michelle Greenwood, Kenrick Ng
Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy: The Patient, Nursing and Physician Perspective. Oncology and therapy 8 (2) (2020)

Kenrick Ng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kenrick Ng